000 | 00838 am a2200277Ia 4500 | ||
---|---|---|---|
999 |
_c8872 _d8872 |
||
001 | ocn805010249 | ||
003 | OCoLC | ||
005 | 20190413152539.0 | ||
008 | 120726s2012 enkdh 000 0 eng d | ||
015 |
_aGBB274275 _2bnb |
||
016 | 7 |
_a016135020 _2Uk |
|
020 | _a9780007350742 (pbk.) | ||
020 | _a0007350740 (pbk.) | ||
035 | _a(OCoLC)805010249 | ||
040 |
_aUKMGB _beng _cUKMGB _dOCLCO _dYDXCP _dEUW _dYNK |
||
082 | 0 | 4 |
_a338.476151 _223 |
090 | _aHD9665.5 | ||
100 | 1 | _aGoldacre, Ben. | |
245 | 1 | 0 |
_aBad pharma : _bhow drug companies mislead doctors and harm patients / _cBen Goldacre. |
260 |
_aLondon : _bFourth Estate, _c2012. |
||
300 |
_axvii, 430 p. : _bcharts, facsims. ; _c22 cm. |
||
650 | 0 |
_aPharmaceutical industry _xCorrupt practices. |
|
650 | 2 |
_aDrug Industry _xethics. |
|
910 | _aAC | ||
942 |
_2fc _cNFIC |